Akero Therapeutics Inc

📅 Upcoming

🕒 Recent(90d)

News

• A booming business on Wall Street would love more biotechs to quietly die
  Once disparaged, reverse mergers have become so popular that some deal experts question whether there are enough quality shell companies to meet the demand.
  biopharma_dive · 23d ago
• A COPD drug from China draws $115M in venture funding
  Expedition Therapeutics, which has raised nearly $300 million to date, is studying a drug it believes to have notable advantages over other COPD treatments either in development or on the market.
  biopharma_dive · 1mo ago
• Judge orders Apple Tree partner to forfeit oversight of venture fund
  The ruling from a Cayman Islands court adds a new wrinkle to an ongoing legal dispute that’s already resulted in a bankruptcy filing — and a bid by general partner Seth Harrison for the firm’s port…
  biopharma_dive · 2mo ago
• Fresh off buyout, Akero execs reunite to advance long-acting psoriasis pill
  Set to go public via a reverse merger, Avere has licensed from a prolific Chinese drugmaker rights to a potential threat to medicines like Skyrizi and Icotyde.
  biopharma_dive · 2mo ago
• STAT+: Akero team, backed by Fairmount, launches new immunology company
  FDA approves injectable Leqembi, another post-Makary reversal, and other biotech news from The Readout
  stat · 2mo ago
• Former Akero team announces new I&I company, Avere, with China drug
  Everything around China biotech really does seem to be speeding up. On Tuesday, the former executive team behind Akero Therapeutics unveiled a new company, a pipeline drug from China and a reverse…
  endpoints · 2mo ago